IGM Biosciences Inc to Discuss Global Collaboration Agreement with Sanofi - Conference Call Transcript

Mar 29, 2022 / 12:00PM GMT

Good day, and thank you for standing by. Welcome to the IGM-Sanofi Collaboration Agreement Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to Fred Schwarzer, Chief Executive Officer. Please go ahead, sir.

Fred M. Schwarzer - IGM Biosciences, Inc. - CEO, President & Director

Thank you, operator, and welcome to all of you for joining us on this call. I'm joined today by Misbah Tahir, Chief Financial Officer; Dr. Chris Takimoto, Chief Medical Officer; and Dr. Mary Beth Harler, President, IGM Autoimmunity and Inflammation.

We're excited to share with you more information on the collaboration and license agreement with Sanofi which was announced today. This collaboration will involve multiple targets in oncology, autoimmunity and inflammation, and expands our research and development pipeline. We're very pleased to be working with such an experienced and strong partner as Sanofi. They have repeatedly demonstrated their

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
4.6 out of 5 Trustpilot